Literature DB >> 9708927

In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma.

C P Morales1, E L Lee, J W Shay.   

Abstract

BACKGROUND: The rate of incidence of esophageal adenocarcinoma has surpassed that of all other malignancies in the U.S. Esophageal adenocarcinoma arises from Barrett's esophagus through the multistep accumulation of genetic mutations in metaplastic cells, accompanied by histologic changes from metaplasia to low grade and high grade dysplasia and finally to carcinoma. Although telomerase activity has been demonstrated in 85-90% of human cancers, to the authors' knowledge there are no reports regarding esophageal adenocarcinoma. The objective of this study was to determine whether telomerase RNA is increased in esophageal adenocarcinoma and at what point in the histologic progression such an increase occurs.
METHODS: Formalin-fixed, paraffin-embedded esophageal biopsies from patients with Barrett's esophagus and surgical resection specimens of esophageal adenocarcinoma containing varying stages of neoplastic progression were obtained. Adjacent sections from each specimen were evaluated by routine histology and in situ hybridization for the RNA component of human telomerase.
RESULTS: The authors found that 100% of esophageal adenocarcinomas and high grade dysplasias were strongly positive for telomerase RNA. Basal crypt cells of Barrett's metaplasia demonstrated weak to moderate telomerase RNA in 70% of cases, whereas 90% of low grade dysplasias had moderate levels of telomerase RNA.
CONCLUSIONS: The results of this study showed that 1) Barrett's epithelium may contain a population of immortalized cells, 2) a marked increase in the level of telomerase RNA accompanies the transition from low grade to high grade dysplasia, and 3) high levels of telomerase RNA accompany the development of esophageal adenocarcinoma in the vast majority of cases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708927

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.

Authors:  R V Lord; D Salonga; K D Danenberg; J H Peters; T R DeMeester; J M Park; J Johansson; K A Skinner; P Chandrasoma; S R DeMeester; C G Bremner; P I Tsai; P V Danenberg
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

Review 2.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 3.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 4.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

5.  Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.

Authors:  Masood A Shammas; Aamer Qazi; Ramesh B Batchu; Robert C Bertheau; Jason Y Y Wong; Manjula Y Rao; Madhu Prasad; Diptiman Chanda; Selvarangan Ponnazhagan; Kenneth C Anderson; Christopher P Steffes; Nikhil C Munshi; Immaculata De Vivo; David G Beer; Sergei Gryaznov; Donald W Weaver; Raj K Goyal
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

Review 6.  Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma.

Authors:  John M Abraham; Stephen J Meltzer
Journal:  Gastroenterology       Date:  2017-05-18       Impact factor: 22.682

7.  Telomere shortening with aging in human esophageal mucosa.

Authors:  K Takubo; K Nakamura; N Izumiyama; M Sawabe; T Arai; Y Esaki; Y Tanaka; K Mafune; M Fujiwara; M Kammori; K Sasajima
Journal:  Age (Omaha)       Date:  1999-07

Review 8.  Biology of telomeres: importance in etiology of esophageal cancer and as therapeutic target.

Authors:  Jagannath Pal; Jason S Gold; Nikhil C Munshi; Masood A Shammas
Journal:  Transl Res       Date:  2013-10-01       Impact factor: 7.012

Review 9.  Reflux esophagitis, high-grade neoplasia, and early Barrett's carcinoma-what is the place of the Merendino procedure?

Authors:  A H Hölscher; D Vallböhmer; C Gutschow; E Bollschweiler
Journal:  Langenbecks Arch Surg       Date:  2008-11-07       Impact factor: 3.445

Review 10.  Esophageal adenocarcinoma arising in Barrett esophagus.

Authors:  Hui Ying Zhang; Stuart Jon Spechler; Rhonda F Souza
Journal:  Cancer Lett       Date:  2008-08-13       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.